These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 2899659)
1. Potentiation of the gastric antisecretory activity of histamine H2-receptor antagonists by clebopride. Fernández AG; Massingham R; Roberts DJ Methods Find Exp Clin Pharmacol; 1988 May; 10(5):285-93. PubMed ID: 2899659 [TBL] [Abstract][Full Text] [Related]
2. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs. Katz LB; Tobia AJ; Shriver DA J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642 [TBL] [Abstract][Full Text] [Related]
3. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine. Katz LB; Scott CK; Shriver DA J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172 [TBL] [Abstract][Full Text] [Related]
4. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration. Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of gastric acid secretion by H2-receptor antagonists. Nielsen ST Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):151-60. PubMed ID: 2876686 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine. Katz LB; Scott CK; Shriver DA J Pharmacol Exp Ther; 1986 Aug; 238(2):587-93. PubMed ID: 2874214 [TBL] [Abstract][Full Text] [Related]
8. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine. Cavanagh RL; Usakewicz JJ; Buyniski JP J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the H2 receptor antagonist and gastric acid antisecretory properties of Wy-45,727. Nielsen ST J Pharmacol Exp Ther; 1987 Aug; 242(2):607-13. PubMed ID: 2886646 [TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro effects of CM 57755, a new gastric antisecretory agent acting on histamine H2 receptors. Lavezzo A; Manzoni L; Aureggi G; Nisato D; Bianchetti A; Carminati P Int J Tissue React; 1984; 6(2):155-65. PubMed ID: 6145676 [TBL] [Abstract][Full Text] [Related]
11. Effects of N-(3-[3-(1-piperidinylmethyl)phenoxy]propyl)-acetoxyacetamide hydrochloride (TZU-0460), a histamine H2-receptor antagonist, on gastric acid secretion and ulcer formation. Tarutani M; Sakuma H; Shiratsuchi K; Mieda M Arzneimittelforschung; 1985; 35(5):844-8. PubMed ID: 2862875 [TBL] [Abstract][Full Text] [Related]
12. Effects of successive doses of nizatidine, cimetidine and ranitidine on serum gastrin level and gastric acid secretion. Yamaji Y; Omata T; Abe T; Yoshida A; Ueki S; Aita H; Morita H; Chaki K; Segawa Y; Kurimoto T Arzneimittelforschung; 1991 Sep; 41(9):954-7. PubMed ID: 1796924 [TBL] [Abstract][Full Text] [Related]
13. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients. Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789 [TBL] [Abstract][Full Text] [Related]
14. Validation of a conscious rat model for the discovery of novel agents that inhibit gastric acid secretion. Campbell CA; Gaskin PJ; Darton J; Chiu P; Lee K; McLean PG Eur J Pharmacol; 2008 Jul; 589(1-3):260-3. PubMed ID: 18571645 [TBL] [Abstract][Full Text] [Related]
15. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats. Amagase K; Kato S; Yamamoto H; Okabe S Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310 [TBL] [Abstract][Full Text] [Related]
16. Simple approach to assess potentiated drug combinations in clinical trials: studies with pirenzepine plus H2-receptor antagonists. Pöch G; Londong W Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):283-7. PubMed ID: 2862111 [TBL] [Abstract][Full Text] [Related]
17. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist. Brittain RT; Daly MJ Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770 [TBL] [Abstract][Full Text] [Related]
18. Effects of H2-receptor antagonists upon physiological acid secretory states in animals. Pendleton RG; Cook PG; Shepherd-Rose A; Mangel AW J Pharmacol Exp Ther; 1985 Apr; 233(1):64-9. PubMed ID: 2858583 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the gastric antisecretory and antiulcer potencies of telenzepine, pirenzepine, ranitidine and cimetidine in the rat. Riedel R; Bohnenkamp W; Eltze M; Heintze K; Prinz W; Kromer W Digestion; 1988; 40(1):25-32. PubMed ID: 3234616 [TBL] [Abstract][Full Text] [Related]
20. Effect of the new H2-receptor antagonist mifentidine on gastric acid secretion in the cat: comparison with cimetidine and ranitidine. Scarpignato C; Tramacere R; Tangwa M; Bertaccini G Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):142-51. PubMed ID: 2864903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]